Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Bortezomib/dexamethasone[2] Bortezomib,
Dexamethasone		[2] Dexamethasone ,
Bortezomib 💬 		[2] NR3C1,
PSMB5 💬 		[9] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬[1] 283 💬
2Bortezomib/Dexamethasone (BD), Followed By Autologous STC & Maintenance Bortezomib/Dexamethasone[2] Bortezomib,
Dexamethasone		[2] Dexamethasone ,
Bortezomib 💬 		[2] NR3C1,
PSMB5 💬 		[9] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬[1] 28 💬
3Bupivacaine/epinephrine/dexamethasone[3] Bupivacaine (ReadySharp Anesthetics plus Dexamethasone),
Dexamethasone,
Epinephrine		[3] Epinephrine ,
Dexamethasone ,
Bupivacaine 💬 		[15] ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3,
NR3C1,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		[16] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 96 💬
4Combination of Protein A Immunoadsorption, Rituximab, Dexamethasone plus Azathioprine[3] Azathioprine,
Dexamethasone,
Rituximab		[3] Azathioprine ,
Dexamethasone ,
Rituximab 💬 		[2] MS4A1,
NR3C1 💬 		[2] Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬[1] 35 💬
5Control intervention (no dexamethasone)[1] Dexamethasone[1] Dexamethasone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 46 💬
6Conventional Glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone)[7] Acetate,
Cortisone,
Cortisone acetate,
Dexamethasone,
Hydrocortisone,
Prednisolone,
Prednisone		[6] Hydrocortisone ,
Dexamethasone ,
Prednisolone ,
Prednisone ,
Cortisone acetate ,
Cortisone 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 81 💬
7Cyclophosphamide, bortezomib, and Dexamethasone (CyBorD) regimen[3] Bortezomib,
Cyclophosphamide,
Dexamethasone		[4] Cyclophosphamide ,
Dexamethasone ,
Bortezomib ,
Cyclophosphamide 💬 		[2] NR3C1,
PSMB5 💬 		[9] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬[1] 28 💬
8Cyclophosphamide, Bortezomib, dexamethasone[3] Bortezomib,
Cyclophosphamide,
Dexamethasone		[4] Cyclophosphamide ,
Dexamethasone ,
Bortezomib ,
Cyclophosphamide 💬 		[2] NR3C1,
PSMB5 💬 		[9] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬[1] 28 💬
9Cyclophosphamide, Bortezomib, dexamethasone plus Daratumumab[4] Bortezomib,
Cyclophosphamide,
Daratumumab,
Dexamethasone		[5] Cyclophosphamide ,
Dexamethasone ,
Bortezomib ,
Cyclophosphamide ,
Daratumumab 💬 		[3] CD38,
NR3C1,
PSMB5 💬 		[16] Alzheimer disease, Amyotrophic lateral sclerosis, Calcium signaling pathway, Hematopoietic cell lineage, Huntington disease, Metabolic pathways, Neuroactive ligand-receptor interaction, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Salivary secretion, Spinocerebellar ataxia 💬[1] 28 💬
10Dexamethasone[1] Dexamethasone[1] Dexamethasone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[22] 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 81, 84, 96, 97, 162, 222, 235, 257, 283, 296, 299 💬
11Dexamethasone (1 cycle)[1] Dexamethasone[1] Dexamethasone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 63 💬
12Dexamethasone (4 cycles)[1] Dexamethasone[1] Dexamethasone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 63 💬
13Dexamethasone (50mg 1dd6, 3 consecutive days/month)[1] Dexamethasone[1] Dexamethasone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 35 💬
14Dexamethasone (or equivalent)[1] Dexamethasone[1] Dexamethasone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 257 💬
15Dexamethasone 0,1 mg Tablets[1] Dexamethasone[1] Dexamethasone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 81 💬
16Dexamethasone 0,5mg[1] Dexamethasone[1] Dexamethasone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 84 💬
17Dexamethasone 0.5mg Tablet[1] Dexamethasone[1] Dexamethasone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 81 💬
18Dexamethasone 0.5mg/5ml solution[1] Dexamethasone[1] Dexamethasone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 35, 162 💬
19Dexamethasone 0.5mg/5ml solution in Mucolox™[1] Dexamethasone[1] Dexamethasone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 35, 162 💬
20Dexamethasone 1,5 mg Tablets[1] Dexamethasone[1] Dexamethasone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 81 💬
21Dexamethasone 21-dihydrogen phosphate[3] Dexamethasone,
Hydrogen,
Phosphate ion		[1] Dexamethasone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 65 💬
22Dexamethasone 21-phosphate[2] Dexamethasone,
Phosphate ion		[1] Dexamethasone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
23Dexamethasone 2mg Tablets[1] Dexamethasone[1] Dexamethasone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 81 💬
24Dexamethasone 4 mg JENAPHARM[1] Dexamethasone[1] Dexamethasone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 28 💬
25Dexamethasone Abcur[1] Dexamethasone[1] Dexamethasone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 63 💬
26Dexamethasone and Rituximab[2] Dexamethasone,
Rituximab		[2] Dexamethasone ,
Rituximab 💬 		[2] MS4A1,
NR3C1 💬 		[2] Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬[1] 63 💬
27Dexamethasone given orally[1] Dexamethasone[1] Dexamethasone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 13 💬
28Dexamethasone oral tablet 8mg (Dexamethasone Krka tablets(8mg), Warsaw, Poland).[1] Dexamethasone[1] Dexamethasone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 235 💬
29Dexamethasone Oral, 10 mg[1] Dexamethasone[1] Dexamethasone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 28 💬
30Dexamethasone Oral, 20 mg[1] Dexamethasone[1] Dexamethasone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 28 💬
31Dexamethasone Parotid Irrigation[1] Dexamethasone[1] Dexamethasone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 53 💬
32DEXAMETHASONE SODIUM PHOSPHATE[2] Dexamethasone,
Phosphate ion		[1] Dexamethasone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[3] 65, 70, 96 💬
33Dexamethasone sodium phosphate (soluzione 25mg/ml)[2] Dexamethasone,
Phosphate ion		[1] Dexamethasone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 65 💬
34Dexamethasone sodium phosphate 250 mg/ 10 ml[2] Dexamethasone,
Phosphate ion		[1] Dexamethasone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 96 💬
35Dexamethasone sodium phosphate 250 mg/10 ml solution[2] Dexamethasone,
Phosphate ion		[1] Dexamethasone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 299 💬
36DEXAMETHASONE SODIUM PHOSPHATE PH. EUR.[2] Dexamethasone,
Phosphate ion		[1] Dexamethasone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 65 💬
37DEXAMETHASONE SODIUM SULFATE[3] Dexamethasone,
Sodium sulfate,
Sulfate ion		[2] Dexamethasone ,
Sodium sulfate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 28 💬
38Dexamethasone soduim phosphate[2] Dexamethasone,
Phosphate ion		[1] Dexamethasone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 13 💬
39Dexamethasone, 40 mg[1] Dexamethasone[1] Dexamethasone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 28 💬
40Dexamethasone, procarbazine[2] Dexamethasone,
Procarbazine		[2] Dexamethasone ,
Procarbazine 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 65 💬
41High dose Dexamethasone pulses[1] Dexamethasone[1] Dexamethasone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 63 💬
42Intraarticular dexamethasone[1] Dexamethasone[1] Dexamethasone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 46 💬
43Intravenous Dexamethasone 1 mg[1] Dexamethasone[1] Dexamethasone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 46 💬
44Lenalidomide and dexamethasone[2] Dexamethasone,
Lenalidomide		[2] Dexamethasone ,
Lenalidomide 💬 		[2] NR3C1,
TNF 💬 		[68] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 16 💬
45Lenalidomide+Dexamethasone[2] Dexamethasone,
Lenalidomide		[2] Dexamethasone ,
Lenalidomide 💬 		[2] NR3C1,
TNF 💬 		[68] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 16 💬
46Lenalidomide, Dexamethasone[2] Dexamethasone,
Lenalidomide		[2] Dexamethasone ,
Lenalidomide 💬 		[2] NR3C1,
TNF 💬 		[68] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 16 💬
47Lenalidomide, Dexamethasone and Cyclophosphamide[3] Cyclophosphamide,
Dexamethasone,
Lenalidomide		[4] Cyclophosphamide ,
Dexamethasone ,
Lenalidomide ,
Cyclophosphamide 💬 		[2] NR3C1,
TNF 💬 		[68] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 28 💬
48Melphalan, thalidomide and dexamethasone[3] Dexamethasone,
Melphalan,
Thalidomide		[3] Dexamethasone ,
Melphalan ,
Thalidomide 💬 		[2] NR3C1,
TNF 💬 		[68] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 28 💬
49MMF and Dexamethasone[1] Dexamethasone[1] Dexamethasone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 222 💬
50Peri-neural Dexamethasone 1 mg[1] Dexamethasone[1] Dexamethasone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 46 💬
51Pomalidomide and Dexamethasone[2] Dexamethasone,
Pomalidomide		[2] Dexamethasone ,
Pomalidomide 💬 		[3] IL6,
NR3C1,
TNF 💬 		[81] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 28 💬
52Romiplostim plus dexamethasone[2] Dexamethasone,
Romiplostim		[2] Dexamethasone ,
Romiplostim 💬 		[2] MPL,
NR3C1 💬 		[3] Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction 💬[1] 63 💬
53SoC: cyclophosphamide, bortezomib, and Dexamethasone (CyBorD)[3] Bortezomib,
Cyclophosphamide,
Dexamethasone		[4] Cyclophosphamide ,
Dexamethasone ,
Bortezomib ,
Cyclophosphamide 💬 		[2] NR3C1,
PSMB5 💬 		[9] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬[1] 28 💬
54Venetoclax MTD with Dexamethasone[2] Dexamethasone,
Venetoclax		[2] Dexamethasone ,
Venetoclax 💬 		[2] BCL2,
NR3C1 💬 		[44] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Amyotrophic lateral sclerosis, Apoptosis, Apoptosis - multiple species, Autophagy - animal, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Colorectal cancer, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Epstein-Barr virus infection, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, Gastric cancer, HIF-1 signaling pathway, Hedgehog signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Human immunodeficiency virus 1 infection, JAK-STAT signaling pathway, Lipid and atherosclerosis, Measles, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Neuroactive ligand-receptor interaction, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platinum drug resistance, Prostate cancer, Protein processing in endoplasmic reticulum, Salmonella infection, Shigellosis, Small cell lung cancer, Sphingolipid signaling pathway, Toxoplasmosis, Tuberculosis, p53 signaling pathway 💬[1] 28 💬